To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
143 Newest Market Studies of GBI Research
rssGBI Research, the leading business intelligence provider, has released its latest research, “Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media”, which provides insights into the ...
GBI Research, leading business intelligence provider, has released its latest research report, entitled “Pharmaceutical Supply Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing”. The report focuses on the current scenario of supply chain ...
GBI Research’s new report, “Accelerating Drugs to Market - Despite Challenges, Adaptive Clinical Trials Reduce Drug Development Costs and Time to Market”, presents various tools and strategies which can accelerate a drug to the market. In this report, GBI Research has studied various hurdles ...
GBI Research, the leading business intelligence provider, has released its latest research “Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures”. The report provides a comprehensive overview of the healthcare ...
GBI Research, leading business intelligence provider, has released its latest research report, entitled “Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development". Over the last decade, protein and peptide-based therapeutics have attracted more and more attention in ...
GBI Research, the leading business intelligence provider, has released its latest research, “Bone Metabolism Therapeutics Market to 2018 - Hyperparathyroidism Sector to Decline in the Absence of New Product Launches and Increased Generic Erosion for Zemplar, Hectorol and Sensipar”, which ...
GBI Research, a leading business intelligence provider, has released its latest research “Biological Strategies in the Emerging Markets - BRIC Countries Will Underpin Future Pharma Growth” which examines two major trends already impacting on marketing strategies in the global pharmaceutical ...
GBI Research, the leading business intelligence provider, has released its latest research, “e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsors to Adopt Novel Technologies”, which provides key ...
GBI Research, the leading business intelligence provider, has released its latest research, “Innovations in Drug Delivery - Broad-based Proprietary Technology Platforms to Address Delivery Efficiency and Improve Patient Compliance”. The report provides an overview of the most exciting ...
GBI Research’s report, “Patient Monitoring Devices Market in Emerging Countries (China, India, Brazil) to 2017 - Increasing Government Spending and Foreign Direct Investment (FDI) to Drive Future Growth” provides key data, information and analysis on the emerging countries’ patient monitoring ...
